Jian Min Fang
Chief Executive Officer bij REMEGEN CO., LTD.
Vermogen: 70 M $ op 29-02-2024
Profiel
Jian Min Fang richtte RemeGen Co., Ltd. en MabPlex International Ltd. op. Dr. Fang is voorzitter van MabPlex International Ltd. en CEO, Executive Director & Chief Scientific Officer bij RemeGen Co., Ltd. Dr. Fang zit ook in het bestuur van de Chinese Pharmaceutical Association, Remegen Medical Research Shanghai Co. Ltd., Remegen Biosciences, Inc. en Remegen Hong Kong Ltd. en Vice-Voorzitter-Antibody Drug Division bij China Medicinal Biotech Association. Dr. Fang behaalde een doctoraat aan de Dalhousie University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
REMEGEN CO. LTD. CLASS H
12.79% | 01-10-2023 | 24 244 500 ( 12.79% ) | 70 M $ | 29-02-2024 |
Actieve functies van Jian Min Fang
Bedrijven | Functie | Begin |
---|---|---|
REMEGEN CO., LTD. | Chief Executive Officer | 04-07-2008 |
MabPlex International Co., Ltd.
MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Founder | 25-06-2013 |
Remegen Medical Research Shanghai Co. Ltd. | Director/Board Member | - |
Remegen Biosciences, Inc. | Director/Board Member | - |
Remegen Hong Kong Ltd. | Director/Board Member | - |
Chinese Pharmaceutical Association | Director/Board Member | - |
China Medicinal Biotech Association | Corporate Officer/Principal | - |
Opleiding van Jian Min Fang
Dalhousie University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 7 |
---|---|
Chinese Pharmaceutical Association | |
China Medicinal Biotech Association | |
MabPlex International Co., Ltd.
MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Health Technology |
RemeGen Co., Ltd. | |
Remegen Medical Research Shanghai Co. Ltd. | |
Remegen Biosciences, Inc. | |
Remegen Hong Kong Ltd. |